In April, Bloomage Biotech 51% of the equity of Beijing YEK, to officially enter the collagen industry. Bloomage Biotech is currently the world’s largest developer, manufacturer, and distributor of hyaluronic acid, occupying 43% of the global market share of hyaluronic acid. After this acquisition, collagen will become another core ingredient of Bloomage Biotech, enriching the company’s product pipeline of bioactives and providing strong support for the company’s future business. YEK’s main products such as collagen sponge and artificial bone can further enrich the existing medical terminal product pipeline of Bloomage Biotech and form a good medical terminal product matrix with a multi-disciplinary layout. (Source: finance.sina)
Visit HPA-China’s Information Hub, CLICK HERE